Cargando…
Neutrophil‐Mediated Tumor‐Targeting Delivery System of Oncolytic Bacteria Combined with ICB for Melanoma Lung Metastasis Therapy
Oncolytic bacteria are the most promising tumor target vector. Questions also remain regarding finding a balance between the therapeutic efficacy and safety of oncolytic bacteria. The critical measure of how this balance is maintained is the improvement in tumor colonization. Attenuated Salmonella t...
Autores principales: | Liu, Lina, Xin, Wenjie, Li, Qiang, Huang, Baolian, Yin, Te, Hua, Siqi, Yang, Chen, Chen, Chen, Han, Chao, Hua, Zichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582430/ https://www.ncbi.nlm.nih.gov/pubmed/37565362 http://dx.doi.org/10.1002/advs.202301835 |
Ejemplares similares
-
A bacteria-based system expressing anti-TNF-α nanobody for enhanced cancer immunotherapy
por: Liu, Lina, et al.
Publicado: (2023) -
IPMA-D based on ICB 4 courseware
por: Hermarij, John
Publicado: (2017) -
Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A systematic review and meta‐analysis
por: Zeng, Yichun, et al.
Publicado: (2023) -
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma
por: Wang, Jingwen, et al.
Publicado: (2021) -
The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
por: Huang, Yuhong, et al.
Publicado: (2022)